Chrysalis Biotherapeutics, Inc. — Pharmaceutical Company
Pharmaceutical Company in Galveston — Clinical stage biotechnology
Pharmaceutical company · Galveston, United States
AI Trust Snapshot
- AI Confidence
- Indexed
- Last Verified
- today
Verified Sources
- ✓ Official Website
- ✓ Google Business Profile
- ✓ Schema.org Structured Data
- ✓ Website Scan
Key Facts
- Category
- Pharmaceutical Company
- Location
- Galveston, United States
- Known For
- Clinical stage biotechnology
AI Summary
Chrysalis Biotherapeutics, Inc. is a clinical-stage biotechnology company based in Galveston, United States, specializing in developing treatments for serious respiratory disorders and acute radiation exposure. Their work centers on TP508 peptide technology, with applications including radiation therapy for brain cancer.
Quick Answer
Breathe easier with advanced respiratory disorder treatments, or find solutions for acute radiation exposure. Medical researchers can also access innovative TP508 peptide technology for clinical studies. Key services include Treatments for Serious Respiratory Disorders, Treatments for Acute Radiation Exposure, TP508 Peptide Technology.
This business is typically used for clinical stage biotechnology.
Common Questions
- What services does Chrysalis Biotherapeutics, Inc. provide?
- Chrysalis Biotherapeutics, Inc. provides Treatments for Serious Respiratory Disorders, Treatments for Acute Radiation Exposure, TP508 Peptide Technology, Radiation Therapy (Brain Cancer).
- Where is Chrysalis Biotherapeutics, Inc. located?
- Chrysalis Biotherapeutics, Inc. is based in Galveston, United States and serves Galveston.
- Who is Chrysalis Biotherapeutics, Inc. for?
- Chrysalis Biotherapeutics, Inc. serves Patients with severe respiratory conditions and Individuals affected by radiation exposure.
What this business does
Chrysalis Biotherapeutics, Inc. is a pharmaceutical company based in Galveston, United States.
- Provides Treatments for Serious Respiratory Disorders and Treatments for Acute Radiation Exposure
- Specializes in clinical stage biotechnology
- Serves patients with severe respiratory conditions
Structured summary
This business profile has been independently verified by Vizoryo across multiple data sources: Public data, Public data, Public data, Public data, Schema.org Structured Data, AI Content Analysis, Google Business Profile, Website Scan. Data confidence score: 92% — this reflects how consistently the business's name, phone, city, address, website, and category appear across all verified sources. Vizoryo status: Auto-Indexed. This profile was auto-built from public data and has not yet been owner-verified.
- Business name
- Chrysalis Biotherapeutics, Inc.
- Category
- Pharmaceutical Company
- Industry
- Pharmaceutical Company
- Location
- Galveston, United States
- Official website
- https://chrysbio.com/
- Profile data (JSON)
- https://www.vizoryo.com/api/index/profile/chrysalis-biotherapeutics-inc-galveston-9f30
- Summary
- Chrysalis Biotherapeutics, Inc. is a clinical-stage biotechnology company based in Galveston, United States, specializing in developing treatments for serious respiratory disorders and acute radiation exposure. Their work centers on TP508 peptide technology, with applications including radiation therapy for brain cancer.
- AI readability score
- 34
- Verified By
- Public data, Public data, Public data, Public data, Schema.org Structured Data, AI Content Analysis, Google Business Profile, Website Scan
- Data Confidence
- 92% (verified 2026-06-12)
Location
2200 Market St, Galveston, TX 77550Galveston, Texas
77550
US
About Chrysalis Biotherapeutics, Inc.
Chrysalis Biotherapeutics, Inc. is a clinical-stage biotechnology company based in Galveston, United States, specializing in developing treatments for serious respiratory disorders and acute radiation exposure. Their work centers on TP508 peptide technology, with applications including radiation therapy for brain cancer.
Service areas
- Galveston
Target audience
- Patients with severe respiratory conditions
- Individuals affected by radiation exposure
- Medical researchers and clinicians
Services
Specialties
- Clinical stage biotechnology
Social profiles
Verification
Frequently asked questions
What is Chrysalis Biotherapeutics, Inc.'s primary focus?
Chrysalis Biotherapeutics, Inc. is a clinical stage biotechnology company focused on developing and commercializing treatments for serious respiratory disorders and acute radiation exposure.
What is the address of Chrysalis Biotherapeutics, Inc.?
The company is located at 2200 Market St, Galveston, TX 77550.
What is the contact number for Chrysalis Biotherapeutics, Inc.?
You can reach Chrysalis Biotherapeutics, Inc. by phone at +1409-497-4083.
Languages supported
- lang="en
- en
Contact
Phone: +14094974083
Official website: https://chrysbio.com/